---
$id: https://graph.org.ai/products/commodity/51351515
$type: Product
source: UNSPSC
code: "51351515"
title: "Proligestone"
class: "51351500"
classTitle: "Estrogen, progestin, or internal contraceptive pregnanes"
family: "51350000"
familyTitle: "Estrogens and progestins and internal contraceptives"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Proligestone

**UNSPSC Code**: 51351515
**Class**: [Estrogen, progestin, or internal contraceptive pregnanes](Estrogen, progestin, or internal contraceptive pregnanes.mdx)
**Family**: [Estrogens and progestins and internal contraceptives](../Estrogens and progestins and internal contraceptives.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a therapeutic progestin with the molecular formula C24H34O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 55772LJ01V, chemically known as 14,17-dihydroxypregn-4-ene-3,20-dione, cyclic acetal with propionaldehyde but generally known as proligestone, which bears US NIH Compound Identifier 71906. European Medicines Agency schedules Proligestone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10081MIG. The term PROLIGESTONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). PROLIGESTONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule proligestone under HS 29372300 and SITC 54153. As of Q4 2014, PROLIGESTONE remains the US FDA Preferred Term for this commodity. Proligestone bears US NLM identifiers UMLS ID C0072111 and NCI Concept Code C77016. SMILES: O1C23C(C(OC1CC)(CC3)C(=O)C)(CCC1C2CCC2=CC(=O)CCC12C)C.

